WebMar 3, 2024 · WALTHAM, Mass., March 03, 2024 -- Dyne Therapeutics, Inc. , a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven... April 5, 2024 WebApr 7, 2024 · The Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
Dyne Therapeutics, Inc. Appoints Carlo Inert, M.D., to Its Board of ...
WebAug 12, 2024 · CureDuchenne congratulates the incredible Dyne Therapeutics team, who recently announced closing $115M in equity financing to develop transformational therapies for patients with serious muscle diseases. We share this news in celebration with everyone in the greater muscle disease space along with the Duchenne community. WebEd Hurwitz, an accomplished biotech executive and investor, is a Managing Director at MPM Capital and serves as Chairman of MPM portfolio companies BioIntervene and Rekindle Therapeutics and on the board of Dyne Therapeutics, also an MPM portfolio company. Prior to MPM, he was founder and Managing Director of Precision … hoverball original
DEF 14A - SEC
WebMar 3, 2024 · WALTHAM, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors. Dr. … WebApr 11, 2024 · As a Managing Director at Vida, Stefan serves on the Board of Directors for Vigil Neuroscience (“VIGL”), Tectonic Therapeutic, Volastra Therapeutics, and Souffle Therapeutics. He was previously a Board Director or Observer at Praxis Precision Medicines (“PRAX”), Kyverna Therapeutics, Oyster Point Therapeutics (“OYST”), Dyne ... WebNov 2, 2024 · Dyne Therapeutics Announces First Patient Dosed in Phase 1/2 DELIVER Clinical Trial of DYNE-251 for the Treatment of Duchenne Muscular Dystrophy August 29, 2024 Dyne Therapeutics Appoints Francesco Bibbiani, M.D., as Senior Vice President, Head of Development hover ball plane crazy tutorial